Gain Therapeutics, Inc. is a biotechnology company developing novel small molecule therapeutics using its proprietary Magellan computational drug discovery platform. The platform identifies allosteric binding sites on disease-implicated proteins. Its lead candidate, GT-02287, targets GCase enzyme dysfunction for Parkinson's disease treatment. Additional pipeline programs address lysosomal storage disorders, CNS disorders, metabolic disorders, and oncology through structurally targeted allosteric regulators (STARs).
expected 2026-12-28
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-035188 | EDGAR | 96K words |
| 2025-03-27 | 2024-12-31 | 0001558370-25-003823 | EDGAR | 80K words |
| 2024-03-26 | 2023-12-31 | 0001558370-24-003943 | EDGAR | 80K words |
| 2023-03-23 | 2022-12-31 | 0001558370-23-004460 | EDGAR | 77K words |
| 2022-03-25 | 2021-12-31 | 0001558370-22-004363 | EDGAR | 71K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001104659-26-094048 | EDGAR | 27K words |
| 2025-11-12 | 2025-09-30 | 0001104659-25-110347 | EDGAR | 27K words |
| 2025-08-12 | 2025-06-30 | 0001558370-25-011220 | EDGAR | 26K words |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007747 | EDGAR | 23K words |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015709 | EDGAR | 55K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011589 | EDGAR | 55K words |
| 2024-05-14 | 2024-03-31 | 0001558370-24-008132 | EDGAR | 52K words |
| 2023-11-14 | 2023-09-30 | 0001558370-23-019014 | EDGAR | 52K words |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014499 | EDGAR | 51K words |
| 2023-05-12 | 2023-03-31 | 0001558370-23-009510 | EDGAR | 49K words |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017414 | EDGAR | 54K words |
| 2022-08-08 | 2022-06-30 | 0001558370-22-012533 | EDGAR | 54K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-10-01 | 0001104659-26-112624 | EDGAR | 2K words |
| 2026-09-28 | 0001104659-26-111391 | EDGAR | 1K words |
| 2026-08-11 | 0001104659-26-094041 | EDGAR | 3K words |
| 2026-07-16 | 0001104659-26-084086 | EDGAR | 1K words |
| 2026-03-26 | 0001104659-26-035174 | EDGAR | 3K words |
| 2026-03-18 | 0001104659-26-029968 | EDGAR | 2K words |
| 2026-02-03 | 0001104659-26-009747 | EDGAR | 3K words |
| 2025-12-18 | 0001104659-25-122353 | EDGAR | 1K words |
| 2025-11-28 | 0001104659-25-116947 | EDGAR | 1K words |
| 2025-11-12 | 0001104659-25-110343 | EDGAR | 3K words |
104 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001819411 |
| Ticker | GANX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.gaintherapeutics.com |
| Listed | 2021-03-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/GANX (~200 tokens, structured JSON with cryptographic provenance)